|
Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Share data, unless otherwise specified
|
3 Months Ended |
9 Months Ended |
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Sep. 30, 2014
|
Sep. 30, 2013
|
| Revenue: |
|
|
|
|
| Licensing revenue |
$ 200 |
$ 0 |
$ 200 |
$ 0 |
| Royalty revenue |
33 |
33 |
111 |
33 |
| Total revenue |
233 |
33 |
311 |
33 |
| Operating expenses: |
|
|
|
|
| Research and development |
4,189 |
1,351 |
11,481 |
1,785 |
| General and administrative |
2,682 |
2,990 |
7,836 |
5,213 |
| Amortization of intangibles |
41 |
172 |
123 |
172 |
| Impairment of intangibles |
0 |
1,576 |
0 |
1,576 |
| Total operating expenses |
6,912 |
6,089 |
19,440 |
8,746 |
| Other income (expense): |
|
|
|
|
| Interest and other income |
18 |
1 |
43 |
1 |
| Interest and other expense |
0 |
(13) |
0 |
(186) |
| Change in fair value of warrant liability |
0 |
3 |
0 |
15 |
| Total other income (expense), net |
18 |
(9) |
43 |
(170) |
| Net loss from continuing operations |
(6,661) |
(6,065) |
(19,086) |
(8,883) |
| Net income (loss) from discontinued operations (including gain on disposal of $- and $1,149 for the three and nine months ended September 30, 2014) |
58 |
(1,337) |
1,195 |
(1,337) |
| Net loss |
(6,603) |
(7,402) |
(17,891) |
(10,220) |
| Net loss per share: |
|
|
|
|
| Net loss per share from continuing operations, basic and diluted |
$ (0.34) |
$ (0.63) |
$ (1.14) |
$ (2.41) |
| Net income (loss) per share from discontinued operations, basic and diluted |
$ 0.00 |
$ (0.14) |
$ 0.07 |
$ (0.36) |
| Net loss per share, basic and diluted |
$ (0.34) |
$ (0.77) |
$ (1.07) |
$ (2.77) |
| Weighted average number of shares used to compute net loss per share of common stock, basic and diluted |
19,330,888 |
9,669,320 |
16,778,047 |
3,683,156 |
| Other comprehensive loss: |
|
|
|
|
| Net loss |
(6,603) |
(7,402) |
(17,891) |
(10,220) |
| Unrealized loss on investments |
(10) |
0 |
(9) |
0 |
| Comprehensive loss |
$ (6,613) |
$ (7,402) |
$ (17,900) |
$ (10,220) |